Novel medical therapies for pituitary tumors

Mostrar todas las versiones(2)

Despite considerable progress, there is still no medical treatment available for some kinds of pituitary tumors, in particular hormone inactive adenomas and corticotroph pituitary tumors. Surgical removal or at least debulking of the tumor is the only option to treat these kinds of tumors apart from...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Theodoropoulou, M., Labeur, M., Paez Pereda, M., Haedo, M., Perone, M.J., Renner, U., Arzt, E., Stalla, G.K.
Formato:	SER
Materias:	angiopeptin bim 23 a 387 bim 23 a 760 bromocriptine cabergoline dopamine receptor stimulating agent gamma interferon octreotide pasireotide quinagolide retinoic acid unclassified drug acromegaly cancer chemotherapy cancer radiotherapy cancer surgery Cushing syndrome growth hormone secreting adenoma human hypophysis tumor multimodality cancer therapy neuroendocrine tumor nonhuman priority journal prolactinoma review Dopamine Dopamine Agonists Humans Interferon-gamma Pituitary Neoplasms Somatostatin Tretinoin
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_03013073_v38_n_p158_Theodoropoulou
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

id	todo:paper_03013073_v38_n_p158_Theodoropoulou
record_format	dspace
spelling	todo:paper_03013073_v38_n_p158_Theodoropoulou2023-10-03T15:18:19Z Novel medical therapies for pituitary tumors Theodoropoulou, M. Labeur, M. Paez Pereda, M. Haedo, M. Perone, M.J. Renner, U. Arzt, E. Stalla, G.K. angiopeptin bim 23 a 387 bim 23 a 760 bromocriptine cabergoline dopamine receptor stimulating agent gamma interferon octreotide pasireotide quinagolide retinoic acid unclassified drug acromegaly cancer chemotherapy cancer radiotherapy cancer surgery Cushing syndrome growth hormone secreting adenoma human hypophysis tumor multimodality cancer therapy neuroendocrine tumor nonhuman priority journal prolactinoma review Dopamine Dopamine Agonists Humans Interferon-gamma Pituitary Neoplasms Somatostatin Tretinoin Despite considerable progress, there is still no medical treatment available for some kinds of pituitary tumors, in particular hormone inactive adenomas and corticotroph pituitary tumors. Surgical removal or at least debulking of the tumor is the only option to treat these kinds of tumors apart from rarely applied radiotherapy. Moreover, treatment resistance is present in a considerable proportion of patients bearing pituitary tumors, for which medical treatment regimens are already available (prolactinomas, somatotroph adenomas). Thus, novel or improved medical treatment strategies would be desirable. Here, we summarize preclinical and clinical findings about the hormone and growth-suppressive action of various drugs, which will probably lead to novel future medical treatment concepts for pituitary tumors. Copyright © 2010 S. Karger AG, Basel. Fil:Labeur, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Paez Pereda, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Haedo, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. SER info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03013073_v38_n_p158_Theodoropoulou
institution	Universidad de Buenos Aires
institution_str	I-28
repository_str	R-134
collection	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic	angiopeptin bim 23 a 387 bim 23 a 760 bromocriptine cabergoline dopamine receptor stimulating agent gamma interferon octreotide pasireotide quinagolide retinoic acid unclassified drug acromegaly cancer chemotherapy cancer radiotherapy cancer surgery Cushing syndrome growth hormone secreting adenoma human hypophysis tumor multimodality cancer therapy neuroendocrine tumor nonhuman priority journal prolactinoma review Dopamine Dopamine Agonists Humans Interferon-gamma Pituitary Neoplasms Somatostatin Tretinoin
spellingShingle	angiopeptin bim 23 a 387 bim 23 a 760 bromocriptine cabergoline dopamine receptor stimulating agent gamma interferon octreotide pasireotide quinagolide retinoic acid unclassified drug acromegaly cancer chemotherapy cancer radiotherapy cancer surgery Cushing syndrome growth hormone secreting adenoma human hypophysis tumor multimodality cancer therapy neuroendocrine tumor nonhuman priority journal prolactinoma review Dopamine Dopamine Agonists Humans Interferon-gamma Pituitary Neoplasms Somatostatin Tretinoin Theodoropoulou, M. Labeur, M. Paez Pereda, M. Haedo, M. Perone, M.J. Renner, U. Arzt, E. Stalla, G.K. Novel medical therapies for pituitary tumors
topic_facet	angiopeptin bim 23 a 387 bim 23 a 760 bromocriptine cabergoline dopamine receptor stimulating agent gamma interferon octreotide pasireotide quinagolide retinoic acid unclassified drug acromegaly cancer chemotherapy cancer radiotherapy cancer surgery Cushing syndrome growth hormone secreting adenoma human hypophysis tumor multimodality cancer therapy neuroendocrine tumor nonhuman priority journal prolactinoma review Dopamine Dopamine Agonists Humans Interferon-gamma Pituitary Neoplasms Somatostatin Tretinoin
description	Despite considerable progress, there is still no medical treatment available for some kinds of pituitary tumors, in particular hormone inactive adenomas and corticotroph pituitary tumors. Surgical removal or at least debulking of the tumor is the only option to treat these kinds of tumors apart from rarely applied radiotherapy. Moreover, treatment resistance is present in a considerable proportion of patients bearing pituitary tumors, for which medical treatment regimens are already available (prolactinomas, somatotroph adenomas). Thus, novel or improved medical treatment strategies would be desirable. Here, we summarize preclinical and clinical findings about the hormone and growth-suppressive action of various drugs, which will probably lead to novel future medical treatment concepts for pituitary tumors. Copyright © 2010 S. Karger AG, Basel.
format	SER
author	Theodoropoulou, M. Labeur, M. Paez Pereda, M. Haedo, M. Perone, M.J. Renner, U. Arzt, E. Stalla, G.K.
author_facet	Theodoropoulou, M. Labeur, M. Paez Pereda, M. Haedo, M. Perone, M.J. Renner, U. Arzt, E. Stalla, G.K.
author_sort	Theodoropoulou, M.
title	Novel medical therapies for pituitary tumors
title_short	Novel medical therapies for pituitary tumors
title_full	Novel medical therapies for pituitary tumors
title_fullStr	Novel medical therapies for pituitary tumors
title_full_unstemmed	Novel medical therapies for pituitary tumors
title_sort	novel medical therapies for pituitary tumors
url	http://hdl.handle.net/20.500.12110/paper_03013073_v38_n_p158_Theodoropoulou
work_keys_str_mv	AT theodoropouloum novelmedicaltherapiesforpituitarytumors AT labeurm novelmedicaltherapiesforpituitarytumors AT paezperedam novelmedicaltherapiesforpituitarytumors AT haedom novelmedicaltherapiesforpituitarytumors AT peronemj novelmedicaltherapiesforpituitarytumors AT renneru novelmedicaltherapiesforpituitarytumors AT arzte novelmedicaltherapiesforpituitarytumors AT stallagk novelmedicaltherapiesforpituitarytumors
_version_	1782030544011264000

Novel medical therapies for pituitary tumors

Ejemplares similares